FORTREA HOLDINGS INC. Basic Shares Outstanding (Weighted Average)
FORTREA HOLDINGS INC. (FTRE) reported Basic Shares Outstanding (Weighted Average) of 94.80 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-29
- FORTREA HOLDINGS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 94.80M shares, a 4.64% increase year-over-year.
- FORTREA HOLDINGS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 93.60M shares, a 3.88% increase year-over-year.
- FORTREA HOLDINGS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 90.60M shares, a 1.34% increase year-over-year.
- FORTREA HOLDINGS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 90.10M shares, a 1.01% increase year-over-year.
- FORTREA HOLDINGS INC. weighted average number of shares outstanding, basic for fiscal 2024 was 89.50M shares, a 0.79% increase from fiscal 2023.
- FORTREA HOLDINGS INC. weighted average number of shares outstanding, basic for fiscal 2023 was 88.80M shares, a 0.00% change from fiscal 2022.
- FORTREA HOLDINGS INC. weighted average number of shares outstanding, basic for fiscal 2022 was 88.80M shares, a 0.00% change from fiscal 2021.
- FORTREA HOLDINGS INC. weighted average number of shares outstanding, basic for fiscal 2021 was 88.80M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 94.80M shares 10-Q · filed 2026-07-29 | 94.20M shares 10-Q · filed 2026-07-29 | ||
| 2026-03-31 | 93.60M shares 10-Q · filed 2026-05-05 | |||
| 2025-06-30 | 90.60M shares 10-Q · filed 2026-07-29 | 90.40M shares 10-Q · filed 2026-07-29 | 90.17M shares derived: average of 3 quarters · filed 2026-07-29 | 90.03M shares derived: average of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | 90.10M shares 10-Q · filed 2026-05-05 | 89.95M shares derived: average of 2 quarters · filed 2026-05-05 | 89.83M shares derived: average of 3 quarters · filed 2026-05-05 | 89.72M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 89.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 89.70M shares derived: average of 2 quarters · filed 2025-03-03 | 89.60M shares derived: average of 3 quarters · filed 2025-03-03 | 89.50M shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 89.60M shares 10-Q · filed 2024-11-08 | 89.50M shares derived: average of 2 quarters · filed 2024-11-08 | 89.40M shares 10-Q · filed 2024-11-08 | 89.25M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2024-06-30 | 89.40M shares 10-Q · filed 2024-08-12 | 89.30M shares 10-Q · filed 2024-08-12 | 89.13M shares derived: average of 3 quarters · filed 2025-03-03 | 89.05M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2024-03-31 | 89.20M shares 10-Q · filed 2024-05-24 | 89.00M shares derived: average of 2 quarters · filed 2025-03-03 | 88.93M shares derived: average of 3 quarters · filed 2025-03-03 | 88.90M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2023-12-31 | 88.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 88.80M shares derived: average of 2 quarters · filed 2025-03-03 | 88.80M shares derived: average of 3 quarters · filed 2025-03-03 | 88.80M shares 10-K · filed 2025-03-03 |
| 2023-09-30 | 88.80M shares 10-Q · filed 2024-11-08 | 88.80M shares derived: average of 2 quarters · filed 2024-11-08 | 88.80M shares 10-Q · filed 2024-11-08 | 88.80M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | 88.80M shares 10-Q · filed 2024-08-12 | 88.80M shares 10-Q · filed 2024-08-12 | 88.80M shares derived: average of 3 quarters · filed 2025-03-03 | 88.80M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | 88.80M shares 10-Q · filed 2024-05-24 | 88.80M shares derived: average of 2 quarters · filed 2025-03-03 | 88.80M shares derived: average of 3 quarters · filed 2025-03-03 | 88.80M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | 88.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 88.80M shares derived: average of 2 quarters · filed 2025-03-03 | 88.80M shares derived: average of 3 quarters · filed 2025-03-03 | 88.80M shares 10-K · filed 2025-03-03 |
| 2022-09-30 | 88.80M shares 10-Q · filed 2023-11-13 | 88.80M shares derived: average of 2 quarters · filed 2023-11-13 | 88.80M shares 10-Q · filed 2023-11-13 | |
| 2022-06-30 | 88.80M shares 10-Q · filed 2023-08-14 | 88.80M shares 10-Q · filed 2023-08-14 | ||
| 2021-12-31 | 88.80M shares 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |